Fig. 4From: A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinomaThe benefit nomogram to identify optimal candidates among stage IB GAC patients who could obtain survival benefits from chemotherapy (A). The calculated points correspond to a benefit probability. ROC curves of the nomogram in the training (B) and validation (C) cohort. Calibration curves in the training (D) and validation (E) cohortBack to article page